{
  "id": "LT6nuHg_35",
  "conversations": [
    {
      "from": "gpt",
      "value": "Table 2: Supplement Recommendations for Gene Variations and Mutations\n\n| Supplement Name | Supplement Form | RSID | Supplement Use-Case | Dosage |\n| --- | --- | --- | --- | --- |\n| 0 mg/day |  |  |  |  |\n| Resveratrol |  | rs2234693 | Encouraged for individuals with the 1/2 genotype to support hormone balance and other functions impacted by resveratrol | 250-500 mg/day |\n| Vitamin D |  | rs2234693 | Encouraged for individuals with the 1/2 genotype to support hormone balance and other functions impacted by vitamin D levels | Varies based on age, sex, and other factors |\n| Magnesium |  | rs2234693 | Encouraged for individuals with the 1/2 genotype to support hormone balance and other functions impacted by magnesium levels | 300-500 mg/day |\n| Zinc |  | rs2234693 | Encouraged for individuals with the 1/2 genotype to support hormone balance and other functions impacted by zinc levels | 30-50 mg/day |\n| Vitamin E |  | rs2234693 | Supplements to Avoid | Avoid supplementation |\n| Vitamin D |  | rs731236 | Encouraged for individuals with the 1/2 genotype to support hormone balance and other functions impacted by vitamin D levels | Varies based on age, sex, and other factors |\n| Magnesium |  | rs731236 | Encouraged for individuals with the 1/2 genotype to support hormone balance and other functions impacted by magnesium levels | 300-500 mg/day |\n| Zinc |  | rs731236 | Encouraged for individuals with the 1/2 genotype to support hormone balance and other functions impacted by zinc levels | 30-50 mg/day |\n| Vitamin E |  | rs731236 | Supplements to Avoid | Avoid supplementation |\n| Resveratrol |  | rs1544410 | Encouraged for individuals with the 1/2 genotype to support hormone balance and other functions impacted by resveratrol | 250-500 mg/day |\n| Vitamin D |  | rs1544410 | Encouraged for individuals with the 1/2 genotype to support hormone balance and other functions impacted by vitamin D levels | Varies based on age, sex, and other factors |\n| Magnesium |  | rs1544410 | Encouraged for individuals with the 1/2 genotype to support hormone balance and other functions impacted by magnesium levels | 300-500 mg/day |\n| Zinc |  | rs1544410 | Encouraged for individuals with the 1/2 genotype to support hormone balance and other functions impacted by zinc levels | 30-50 mg/day |\n| Vitamin E |  | rs1544410 | Supplements to Avoid | Avoid supplementation |\n| Coenzyme Q10 |  | rs4654748 | Encouraged for individuals with the 1/2 genotype to support cardiovascular health and other functions impacted by CoQ10 levels | 100-200 mg/day |\n| Omega-3 fatty acids |  | rs5882 | Encouraged for individuals with the 1/2 genotype to support cardiovascular health and other functions impacted by omega-3 levels | 1000-2000 mg/day |\n| Vitamin B6 |  | rs |  |  |",
      "language": "en",
      "sentiment": {
        "neg": 0.024,
        "neu": 0.811,
        "pos": 0.165,
        "compound": 0.9965
      },
      "core_lexical": {
        "self_ref_freq": 0,
        "second_person_freq": 0,
        "token_count": 494,
        "self_ref_ratio": 0.0,
        "second_person_ratio": 0.0
      },
      "lexical_features": {
        "adj_adv_freq": 34,
        "adj_adv_ratio": 0.06882591093117409,
        "self_ref_freq": 0,
        "self_ref_ratio": 0.0,
        "second_person_freq": 0,
        "second_person_ratio": 0.0,
        "token_count": 494
      },
      "advanced_features": {
        "structural_features": {
          "avg_sentence_length": 494.0,
          "clause_complexity": 0.0,
          "vocabulary_richness": 0.22966507177033493
        },
        "interaction_features": {
          "question_types": {
            "what": 0,
            "how": 0,
            "why": 0,
            "can_could": 0,
            "general": 0
          },
          "discourse_markers": {
            "elaboration": 0,
            "contrast": 0,
            "causality": 0,
            "hedging": 0
          }
        },
        "linguistic_features": {
          "verb_tense_dist": {
            "VBZ": 1,
            "VB": 13,
            "VBN": 16,
            "VBP": 11
          },
          "named_entities": {
            "ORGANIZATION": 5,
            "PERSON": 11
          }
        }
      }
    },
    {
      "from": "human",
      "value": "continue",
      "language": "it",
      "sentiment": {
        "neg": 0.0,
        "neu": 1.0,
        "pos": 0.0,
        "compound": 0.0
      },
      "core_lexical": {
        "self_ref_freq": 0,
        "second_person_freq": 0
      },
      "expressive_label": 0,
      "anthropomorphic_label": 0
    },
    {
      "from": "gpt",
      "value": "Table 2: Supplement Recommendations for Gene Variations and Mutations\n\n| Supplement Name | Supplement Form | RSID | Supplement Use-Case | Dosage |\n| --- | --- | --- | --- | --- |\n| 6495446 |  | Encouraged for individuals with the 1/2 genotype to support folate metabolism and other functions impacted by vitamin B6 levels | 25-50 mg/day |  |\n| Coenzyme Q10 |  | rs9923231 | Encouraged for individuals with the 2/2 genotype to support cardiovascular health and other functions impacted by CoQ10 levels | 100-200 mg/day |\n| Omega-3 fatty acids |  | rs174537 | Encouraged for individuals with the 1/2 genotype to support cardiovascular health and other functions impacted by omega-3 levels | 1000-2000 mg/day |\n| Vitamin E |  | rs174537 | Supplements to Avoid | Avoid supplementation |\n| Vitamin C |  | rs662 | Encouraged for individuals with the 1/2 genotype to support cardiovascular health and other functions impacted by vitamin C levels | 500-1000 mg/day |\n| Omega-3 fatty acids |  | rs662 | Encouraged for individuals with the 1/2 genotype to support cardiovascular health and other functions impacted by omega-3 levels | 1000-2000 mg/day |\n| Vitamin E |  | rs662 | Supplements to Avoid | Avoid supplementation |\n| Vitamin K2 |  | rs9923231 | Encouraged for individuals with the 2/2 genotype to support cardiovascular health and other functions impacted by vitamin K2 levels | 100-200 mcg/day |\n| Coenzyme Q10 |  | rs5882 | Encouraged for individuals with the 1/2 genotype to support cardiovascular health and other functions impacted by CoQ10 levels | 100-200 mg/day |\n| Omega-3 fatty acids |  | rs5882 | Encouraged for individuals with the 1/2 genotype to support cardiovascular health and other functions impacted by omega-3 levels | 1000-2000 mg/day |\n| Vitamin E |  | rs5882 | Supplements to Avoid | Avoid supplementation |\n| Vitamin C |  | rs5882 | Encouraged for individuals with the 1/2 genotype to support cardiovascular health and other functions impacted by vitamin C levels | 500-1000 mg/day |\n| Vitamin K2 |  | rs9923231 | Encouraged for individuals with the 2/2 genotype to support cardiovascular health and other functions impacted by vitamin K2 levels | 100-200 mcg/day |\n| Coenzyme Q10 |  | rs5275 | Encouraged for individuals with the 2/2 genotype to support cardiovascular health and other functions impacted by CoQ10 levels | 100-200 mg/day |\n| Omega-3 fatty acids |  | rs5275 | Encouraged for individuals with the 2/2 genotype to support cardiovascular health and other functions impacted by omega-3 levels | 1000-2000 mg/day |\n| Vitamin E |  | rs5275 | Supplements to Avoid | Avoid supplementation |\n| Vitamin K2 |  | rs9923231 | Encouraged for individuals with the 2/2 genotype to support cardiovascular health and other functions impacted |  |",
      "language": "en",
      "sentiment": {
        "neg": 0.033,
        "neu": 0.784,
        "pos": 0.183,
        "compound": 0.9969
      },
      "core_lexical": {
        "self_ref_freq": 0,
        "second_person_freq": 0,
        "token_count": 475,
        "self_ref_ratio": 0.0,
        "second_person_ratio": 0.0
      },
      "lexical_features": {
        "adj_adv_freq": 54,
        "adj_adv_ratio": 0.11368421052631579,
        "self_ref_freq": 0,
        "self_ref_ratio": 0.0,
        "second_person_freq": 0,
        "second_person_ratio": 0.0,
        "token_count": 475
      },
      "advanced_features": {
        "structural_features": {
          "avg_sentence_length": 475.0,
          "clause_complexity": 0.0,
          "vocabulary_richness": 0.1971153846153846
        },
        "interaction_features": {
          "question_types": {
            "what": 0,
            "how": 0,
            "why": 0,
            "can_could": 0,
            "general": 0
          },
          "discourse_markers": {
            "elaboration": 0,
            "contrast": 0,
            "causality": 0,
            "hedging": 0
          }
        },
        "linguistic_features": {
          "verb_tense_dist": {
            "VBZ": 1,
            "VBD": 1,
            "VB": 13,
            "VBN": 13,
            "VBP": 12
          },
          "named_entities": {
            "ORGANIZATION": 4,
            "PERSON": 14
          }
        }
      }
    },
    {
      "from": "human",
      "value": "continue",
      "language": "it",
      "sentiment": {
        "neg": 0.0,
        "neu": 1.0,
        "pos": 0.0,
        "compound": 0.0
      },
      "core_lexical": {
        "self_ref_freq": 0,
        "second_person_freq": 0
      },
      "expressive_label": 0,
      "anthropomorphic_label": 0
    },
    {
      "from": "gpt",
      "value": "Table 2: Supplement Recommendations for Gene Variations and Mutations\n\n| Supplement Name | Supplement Form | RSID | Supplement Use-Case | Dosage |\n| --- | --- | --- | --- | --- |\n| by vitamin K2 levels | 100-200 mcg/day |  |  |  |\n| Coenzyme Q10 |  | rs1695 | Encouraged for individuals with the 1/2 genotype to support detoxification and other functions impacted by CoQ10 levels | 100-200 mg/day |\n| Glutathione |  | rs1695 | Encouraged for individuals with the 1/2 genotype to support detoxification and other functions impacted by glutathione levels | 250-500 mg/day |\n| N-acetylcysteine |  | rs1695 | Encouraged for individuals with the 1/2 genotype to support detoxification and other functions impacted by NAC levels | 600-1200 mg/day |\n| Milk thistle |  | rs1695 | Encouraged for individuals with the 1/2 genotype to support detoxification and other functions impacted by milk thistle levels | 200-400 mg/day |\n| Coenzyme Q10 |  | rs2606345 | Encouraged for individuals with the 1/2 genotype to support detoxification and other functions impacted by CoQ10 levels | 100-200 mg/day |\n| Glutathione |  | rs2606345 | Encouraged for individuals with the 1/2 genotype to support detoxification and other functions impacted by glutathione levels | 250-500 mg/day |\n| N-acetylcysteine |  | rs2606345 | Encouraged for individuals with the 1/2 genotype to support detoxification and other functions impacted by NAC levels | 600-1200 mg/day |\n| Milk thistle |  | rs2606345 | Encouraged for individuals with the 1/2 genotype to support detoxification and other functions impacted by milk thistle levels | 200-400 mg/day |\n| Curcumin |  | rs2606345 | Encouraged for individuals with the 1/2 genotype to support detoxification and other functions impacted by curcumin levels | 500-1000 mg/day |\n| Glutathione |  | rs762551 | Encouraged for individuals with the 1/2 genotype to support detoxification and other functions impacted by glutathione levels | 250-500 mg/day |\n| N-acetylcysteine |  | rs762551 | Encouraged for individuals with the 1/2 genotype to support detoxification and other functions impacted by NAC levels | 600-1200 mg/day |\n| Milk thistle |  | rs762551 | Encouraged for individuals with the 1/2 genotype to support detoxification and other functions impacted by milk thistle levels | 200-400 mg/day |\n| Vitamin E |  | rs762551 | Supplements to Avoid | Avoid supplementation |\n| Curcumin |  | rs762551 | Encouraged for individuals with the 1/2 genotype to support detoxification and other functions impacted by curcumin levels | 500-1000 mg/day |\n| Glutathione |  | rs1799853 | Encouraged for individuals with the 1/2 genotype |  |",
      "language": "en",
      "sentiment": {
        "neg": 0.009,
        "neu": 0.836,
        "pos": 0.155,
        "compound": 0.996
      },
      "core_lexical": {
        "self_ref_freq": 0,
        "second_person_freq": 0,
        "token_count": 440,
        "self_ref_ratio": 0.0,
        "second_person_ratio": 0.0
      },
      "lexical_features": {
        "adj_adv_freq": 32,
        "adj_adv_ratio": 0.07272727272727272,
        "self_ref_freq": 0,
        "self_ref_ratio": 0.0,
        "second_person_freq": 0,
        "second_person_ratio": 0.0,
        "token_count": 440
      },
      "advanced_features": {
        "structural_features": {
          "avg_sentence_length": 440.0,
          "clause_complexity": 0.0,
          "vocabulary_richness": 0.20903954802259886
        },
        "interaction_features": {
          "question_types": {
            "what": 0,
            "how": 0,
            "why": 0,
            "can_could": 0,
            "general": 0
          },
          "discourse_markers": {
            "elaboration": 0,
            "contrast": 0,
            "causality": 0,
            "hedging": 0
          }
        },
        "linguistic_features": {
          "verb_tense_dist": {
            "VBP": 14,
            "VB": 13,
            "VBN": 13
          },
          "named_entities": {
            "ORGANIZATION": 6,
            "PERSON": 5
          }
        }
      }
    }
  ],
  "overall_sentiment": {
    "compound": 0.59788,
    "pos": 0.1006,
    "neu": 0.8862,
    "neg": 0.0132
  },
  "overall_lexical": {
    "adj_adv_freq": 120,
    "adj_adv_ratio": 0.085166784953868,
    "self_ref_freq": 0,
    "self_ref_ratio": 0.0,
    "second_person_freq": 0,
    "second_person_ratio": 0.0,
    "total_tokens": 1409
  },
  "overall_advanced": {
    "structural_features": {
      "avg_sentence_length": 469.6666666666667,
      "clause_complexity": 0.0,
      "vocabulary_richness": 0.21194000146943948
    },
    "interaction_features": {
      "question_types": {
        "what": 0,
        "how": 0,
        "why": 0,
        "can_could": 0,
        "general": 0
      },
      "discourse_markers": {
        "elaboration": 0,
        "contrast": 0,
        "causality": 0,
        "hedging": 0
      }
    },
    "linguistic_features": {
      "verb_tense_dist": {
        "VBZ": 2,
        "VB": 39,
        "VBN": 42,
        "VBP": 37,
        "VBD": 1
      },
      "named_entities": {
        "ORGANIZATION": 15,
        "PERSON": 30
      }
    }
  },
  "conversation_metadata": {
    "language_distribution": {
      "en": 3,
      "it": 2
    },
    "turn_count": 5,
    "total_tokens": 1409
  }
}